CIK 0001713863 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 07/31
| FY2025 | FY2023 | FY2022 | |
|---|---|---|---|
| Revenue (USD) | 917000 | 410000 | 802000 |
| Net income (USD) | -30.5 M | -124.7 M | -23.1 M |
| Diluted EPS (USD/shares) | -1.04 | -6.31 | -1.49 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-30 | 8-K | CURRENT REPORT items 7.01,8.01,9.01 | 2026-09-30 |
| 2026-09-23 | 4 | 4 | 2026-09-21 |
| 2026-07-31 | 4 | 4 | 2026-07-29 |
| 2026-07-08 | 8-K | CURRENT REPORT items 7.01,9.01 | 2026-07-08 |
| 2026-06-23 | 4 | 4 | 2026-06-21 |
| 2026-06-16 | 4 | 4 | 2026-06-13 |
| 2026-06-11 | 10-Q | QUARTERLY REPORT | 2026-04-30 |
| 2026-06-11 | 8-K | CURRENT REPORT items 2.02,9.01 | 2026-06-11 |
| 2026-06-10 | 8-K | CURRENT REPORT items 7.01,8.01,9.01 | 2026-06-10 |
| 2026-04-22 | 8-K | CURRENT REPORT items 7.01,8.01,9.01 | 2026-04-22 |
| 2026-03-24 | 4 | 4 | 2026-03-21 |
| 2026-03-17 | 4 | 4 | 2026-03-13 |
| 2026-03-16 | 10-Q | QUARTERLY REPORT | 2026-01-31 |
| 2026-03-16 | 8-K | CURRENT REPORT items 2.02,9.01 | 2026-03-16 |
| 2026-01-30 | 4 | 4 | 2026-01-28 |
| 2026-01-29 | 4 | 4 | 2026-01-28 |
| 2026-01-29 | 4 | 4 | 2026-01-28 |
| 2026-01-29 | 4 | 4 | 2026-01-28 |
| 2026-01-27 | S-8 | REGISTRATION STATEMENT | |
| 2026-01-15 | 4 | 4 | 2026-01-13 |
| 2026-01-15 | 4 | 4 | 2026-01-13 |
| 2026-01-12 | 8-K | CURRENT REPORT items 5.07 | 2026-01-08 |
| 2025-12-23 | 4 | 4 | 2025-12-21 |
| 2025-12-16 | 4 | 4 | 2025-12-13 |
| 2025-12-12 | 10-Q | QUARTERLY REPORT | 2025-10-31 |
Forms on file (last 1,000): 4 116, 8-K 108, 3 26, 10-Q 26, CORRESP 15, UPLOAD 15, 8-K/A 10, DEF 14A 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RFL (0.002 USD), /gw/filings/filings?ticker=RFL&form=8-K, /gw/filings/facts?ticker=RFL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange